Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.
Stayble Therapeutics has raised $463K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2025.
Stayble Therapeutics's investors include Almi Invest, Chalmers Ventures AB, EISMEA.
Stayble Therapeutics is headquartered in Göteborg, Sweden.
Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.
Stayble Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Stayble Therapeutics — Funding & Investors." VCBacked, May 12, 2025, https://www.vcbacked.co/company/stayble-therapeutics. Accessed September 30, 2026.
VCBacked. (2025). Stayble Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/stayble-therapeutics
{{cite web |title=Stayble Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/stayble-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated